Skip to main content
Fig. 3 | Diagnostic and Prognostic Research

Fig. 3

From: Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case–control study

Fig. 3

TransBioLine sample processing. Blood is collected at visits in standard clinical blood containers. Link-anonymised aliquots of 0.5 ml are stored in barcoded cryovials at − 80 °C prior to transfer on dry ice to the central biobank (ZeBanC, Charité, Berlin, Germany). ALP, alkaline phosphatase; ALT, alanine transaminase; DILI, drug-induced liver injury; TBL, total bilirubin

Back to article page

Diagnostic and Prognostic Research

ISSN: 2397-7523

Contact us